Table 3.
Prior Antibiotic Use (n=99) | No Prior Antibiotic Use (n=1423) | |||||||
---|---|---|---|---|---|---|---|---|
Antibiotic | Tested (n) | Susceptible % (95%CI) | Intermed % | Resistant % | Tested (n) | Susceptible % (95%CI) | Intermed % | Resistant % |
Penicillins | 98 | 49% (39−59)* | 35% | 16% | 1404 | 78% (75−80)* | 14% | 8% |
Cephalosporins§ | 88 | 82% (72−89)* | 15% | 3% | 1203 | 92% (90−93)* | 6% | 2% |
Macrolides | 53 | 55% (41−68)* | 4% | 42% | 889 | 84% (82−87)* | 1% | 15% |
Clindamycin | 43 | 84% (69−93) | 0% | 16% | 528 | 95% (92−96) | 2% | 4% |
Quinolones | 47 | 96% (84−99) | 0% | 4% | 665 | 99% (98−100) | <1% | 1% |
Tetracyclines | 29 | 72% (53−87)* | 3% | 24% | 454 | 94% (91−96)* | 1% | 6% |
Sulfonamides | 34 | 59% (41−75) | 6% | 35% | 572 | 74% (70−77) | 6% | 20% |
Cephalosporin testing includes testing for Ceftriaxone and Cefotaxime
Comparisons made between proportion susceptible among two groups.
Non-overlapping confidence intervals signify significant at p< 0.05 level.